Homogeneous and heterogeneous boosting in prostate radiotherapy: Treatment planning and target dosimetry comparison
Heterogeneous DIL boost implemented by structure-based prescriptions enabled higher TCP improvements for the majority of plans produced for a homogeneous DIL boost.
Authors
- Jonathan Sykes (ORCID: https://orcid.org/0000-0002-3823-3892)
- Annette Haworth (ORCID: https://orcid.org/0000-0003-1382-7747)
- Pejman Rowshanfarzad
- J. Croker (ORCID: https://orcid.org/0000-0002-4425-4614)
- Ben Hug
- Andrew Le (ORCID: https://orcid.org/0009-0000-7904-7765)
- Jeremy Booth (ORCID: https://orcid.org/0000-0003-4004-1109)
- Simon Goodall (ORCID: https://orcid.org/0000-0003-3318-9703)
- Michele Krawiec
- Scott C. Williams (ORCID: https://orcid.org/0000-0002-3751-7703)
- Martin A. Ebert (ORCID: https://orcid.org/0000-0002-6875-0719)
- Yutong Zhao (ORCID: https://orcid.org/0000-0001-6477-0205)
- Shrikant Deshpande
- R. Walther
Institutions
- The University of Sydney (AU)
- The University of Western Australia (AU)
- Royal North Shore Hospital (AU)
- Peter MacCallum Cancer Centre (AU)
- Woolcock Institute of Medical Research (AU)
- Sir Charles Gairdner Hospital (AU)
- Cooperative Trials Group for Neuro-Oncology (AU)
- Sydney Children’s Hospitals Network (AU)
- Shandong First Medical University (CN)
- Claremont Colleges (US)
Publication Details
- Journal
- Radiotherapy and Oncology
- Published
- 2025-05-02
- DOI
- https://doi.org/10.1016/j.radonc.2025.110916
- Citations
- 1
- Primary Topic
- Advanced Radiotherapy Techniques
- Type
- article
- Field-Weighted Citation Impact
- 1.88